Hot Pursuit     27-Jun-23
Zydus Lifesciences Ltd rises for third consecutive session
Zydus Lifesciences Ltd is quoting at Rs 570.75, up 1.59% on the day as on 12:49 IST on the NSE. The stock is up 59.54% in last one year as compared to a 18.23% jump in NIFTY and a 10.09% jump in the Nifty Metal index.

Zydus Lifesciences Ltd is up for a third straight session today. The stock is quoting at Rs 570.75, up 1.59% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.26% on the day, quoting at 18739.5. The Sensex is at 63135.64, up 0.26%. Zydus Lifesciences Ltd has gained around 11.46% in last one month.

Meanwhile, Nifty Metal index of which Zydus Lifesciences Ltd is a constituent, has gained around 6.51% in last one month and is currently quoting at 13388.6, up 0.43% on the day. The volume in the stock stood at 6.08 lakh shares today, compared to the daily average of 11.07 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 570.35, up 1.44% on the day. Zydus Lifesciences Ltd is up 59.54% in last one year as compared to a 18.23% jump in NIFTY and a 10.09% jump in the Nifty Metal index.

The PE of the stock is 33.81 based on TTM earnings ending March 23.

Previous News
  Zydus Lifesciences consolidated net profit rises 26.76% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   14:29 )
  Zydus Life Q3 PAT climbs 27% YoY to Rs 790 cr; board OKs Rs 600 cr share buyback
 ( Hot Pursuit - 09-Feb-24   14:22 )
  Barometers trade higher; Pharma shares advance; Biocon rallies over 3%
 ( Market Commentary - Mid-Session 28-Mar-24   12:32 )
  Zydus Lifesciences receives USFDA approval for Clindamycin Phosphate Gel
 ( Corporate News - 20-Sep-23   18:02 )
  Zydus completes Phase II clinical study of NLRP3 inhibitor ‘Usnoflast (ZYIL1)'
 ( Corporate News - 24-May-24   16:02 )
  Zydus receives USFDA approval for Theophylline ER Tablets
 ( Corporate News - 22-May-24   12:57 )
  Zydus Lifesciences consolidated net profit rises 53.24% in the September 2023 quarter
 ( Results - Announcements 07-Nov-23   12:50 )
  Zydus Life Ahmedabad facility gets 4 USFDA observations
 ( Hot Pursuit - 28-Mar-24   11:03 )
  Zydus Lifesciences Ltd slips for fifth straight session
 ( Hot Pursuit - 30-May-24   13:35 )
  Zydus Life's Ahmedabad facility gets EIR from USFDA
 ( Hot Pursuit - 20-Sep-23   08:19 )
  Zydus Life gains on USFDA nod for prostatic hyperplasia drug
 ( Hot Pursuit - 18-Mar-24   09:40 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top